Innovate Biopharmaceuticals, Inc. (INNT)

Innovate Biopharmaceuticals, Inc. (INNT)

$1.10 USD

0.03 (-2.65%)

Updated Jul 23 6:55pm

Add INNT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 321 in Biotech

See all “A” rated Strong Buy stocks

INNT Daily Price Range
INNT 52-Week Price Range

INNT Stock Chart More Charts

INNT Price/Volume Stats

Current price $1.10
Prev. close $1.13
Day low $1.08
Day high $1.13
50-day MA $1.24
200-day MA $2.29
52-week high $9.68
52-week low $1.07
Volume 228,100
Avg. volume 586,924
Dividend yield N/A
Market Cap 39.47M

Innovate Biopharmaceuticals, Inc. (INNT) Company Bio

Innovate Biopharmaceuticals, Inc., a clinical stage biotechnology company, focuses on developing autoimmune and inflammation therapeutics. Its late-stage clinical pipeline focuses on addressing unmet needs in diseases, such as celiac disease, inflammatory bowel disease (IBD), and nonalcoholic steatohepatitis (NASH). The company's lead drug candidate, larazotide acetate (INN-202), has successfully met its primary endpoint in a Phase 2b efficacy clinical trial for celiac disease. It is also developing INN-108, which is entering into Phase 2 clinical trials for the treatment of mild to moderate ulcerative colitis. In addition, the company owns the global rights to INN-329, a proprietary formulation of secretin, a peptide hormone used to enhance visualization in magnetic resonance cholangiopancreatography procedures. Innovate Biopharmaceuticals, Inc. was founded in 2012 and is based in Raleigh, North Carolina.

INNT News Stream

Event/Time News Detail
Loading, please wait...

INNT Social Stream

Loading social stream, please wait...

View Full INNT Social Stream

INNT Returns

1-mo -3.51%
3-mo -46.08%
6-mo -52.17%
1-year -83.43%
3-year -96.77%
5-year N/A
YTD -52.38%
2018 -62.13%
2017 -65.14%
2016 N/A
2015 N/A
2014 N/A

Page generated in 0.407 seconds.